Dr Nathan Kerr was invited to speak at the official Australian launch of the CyPass Micro-Stent in Melbourne, Australia.

As the surgeon who performed the first commercial CyPass Micro-Stent procedure in Australia, Dr Kerr presented to over 50 ophthalmologists on the safety and outcomes of the procedure with a focus on:

  • Use of the CyPass Micro-Stent combined with cataract surgery to reduce eye pressure and need for glaucoma medications in patients with mild to moderate primary open angle glaucoma
  • Advantages including a fast post-operative recovery, significant eye pressure reduction, and predictable refractive outcomes